A group of MEPs working on plans for the EU’s overall budget from 2014 are pushing for a big boost – to as much as €100 billion - for the next EU research programme, as Maria Da Graça Carvalho, Member of the European Parliament tells Science|Business
It’s six years since Europe led the way and created a regulatory framework for approving generic versions of biopharmaceuticals, or biosimilars. Now similar legislation has been enacted in the US
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.